PT Journal
AU Mares, J
   Stejskal, D
   Vavrouskova, J
   Urbanek, K
   Herzig, R
   Hlustik, P
TI USE OF CYSTATIN C DETERMINATION IN CLINICAL DIAGNOSTICS
SO Biomedical papers
PY 2003
BP 177
EP 180
VL 147
IS 2
DI 10.5507/bp.2003.025
DE Keywords: Cystatin C / Biochemical diagnostics / Alzheimer's dementia / Early atherosclerosis / Vascular aneurysms / Hyperhomocysteinaemia / Neurodegenerative diseases
AB This paper presents a current view of the possible clinical uses of cystatin C determination. Cystatin C is an inhibitor of cysteine proteases, and relatively stable in the systemic circulation it is comparatively easily determined. Although in clinical practice it is known primarily as a relatively reliable and endogenous marker for glomerular filtration, lately cystatin C analysis has been discussed in connection with the diagnostics of a variety of diseases such as early atherosclerosis, Alzheimer's dementia, vascular aneurysms, hyperhomocysteinaemia and other neurodegenerative diseases.
ER